The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Regan Daniel Paul since 2014.
The trader's CIK number is 1571320.
At the time of the last reporting, Regan Daniel Paul was the Chief Commercial Officer of Intercept Pharmaceuticals, Inc.. (stock ticker symbol ICPT).
Also see all insider trading activities at Intercept Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | ICPT | 0 | $0 | 9,993 | $2,030,644 | 9,847 | $371,133 |
2014 | ICPT | 0 | $0 | 28,125 | $11,340,337 | 28,125 | $1,060,030 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-01-30 | ICPT | Option Ex | 9,847 | 37.69 | 371,133 |
2015-01-30 | ICPT | Sale | 9,847 | 203.60 | 2,004,878 |
2015-01-05 | ICPT | Sale | 146 | 176.49 | 25,766 |
2014-08-12 | ICPT | Sale | 8,124 | 325.90 | 2,647,587 |
2014-08-12 | ICPT | Option Ex | 8,124 | 37.69 | 306,193 |
2014-07-03 | ICPT | Sale | 1 | 250.00 | 250 |
2014-07-03 | ICPT | Option Ex | 1 | 37.69 | 37 |
2014-03-05 | ICPT | Sale | 20,000 | 434.62 | 8,692,500 |
2014-03-05 | ICPT | Option Ex | 20,000 | 37.69 | 753,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Regan Daniel Paul (Chief Commercial Officer of Intercept Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.